A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.

Also called NCT03941691

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 108 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03941691
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03941691. Randomized; no masking; primary purpose treatment. Start 2019-04-11 (actual); primary completion 2021-04-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
Condition
Ventricular Septal Defect
Intervention (Device)
Fully Absorbable VSD Occlusion System
Intervention (Device)
VSD Occluder
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)
Collaborator
Shanghai Shape Memory Alloy Co., Ltd. (class: not stated)

Record details

Record id
cardio:ct-nct03941691
Content hash
fa16e292b4ade47feec9916957c123b916fc8b76ba23acbb039cf53c68718d0b